Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Astrazeneca plc crawled time : 12:20 save search
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
Published: 2023-08-03 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
FBIO | $1.81 3.43% 2.23% 190K
|
Health Technology
|
| O: 1.2%
H: 1.52%
C: -4.99%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -2.88%
H: 1.68%
C: 1.53%
conference biotech
Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
RLYB | News | $1.74 -1.7% 3.8% 220K
|
|
| O: -0.34%
H: 4.41%
C: -5.25%
NVO | News | $128.64 2.7% -1.0% 3.5M
|
Health Technology
|
| O: -1.19%
H: 1.41%
C: 1.36%
CRL | News | $240.13 3.26% 0.78% 540K
|
Commercial Services
|
| O: 0.09%
H: 1.73%
C: 1.58%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
Urica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States
Published: 2023-06-29 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
FBIO | $1.81 3.43% 2.23% 190K
|
Health Technology
|
| O: 0.0%
H: 7.55%
C: 7.55%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
topline trial therapeutics
Helocyte Announces $3.22 Million Grant from the National Cancer Institute for Triplex Phase 2 Clinical Trial Program
Published: 2023-06-15 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: 0.97%
H: 0.64%
C: 0.64%
FBIO | $1.81 3.43% 2.23% 190K
|
Health Technology
|
| O: 2.42%
H: 10.78%
C: 7.94%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: 1.68%
H: 1.0%
C: 0.84%
cancer grant program trial phase 2
Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update
Published: 2023-03-31 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: 0.98%
H: 0.07%
C: -0.67%
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -3.26%
H: 12.98%
C: 11.54%
business update financial results
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner
Published: 2023-01-31 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: -0.19%
H: 1.07%
C: 1.06%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -1.22%
H: 0.52%
C: 0.51%
growth
Genprex Announces Safety Review Committee Approves Dose Escalation in Acclaim-1 Phase 1/2 Trial of REQORSA™ in Combination with Tagrisso® in Non-Small Cell Lung Cancer
Published: 2022-08-15 (Crawled : 12:20) - biospace.com/
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: 3.35%
H: 0.0%
C: -0.09%
GNPX | $2.31 6.8% 6.77% 0
|
Health Technology
|
| O: 7.91%
H: 13.09%
C: 9.42%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: 0.92%
H: 0.22%
C: -0.65%
tagrisso lung trial review cancer phase 1
Artelo Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-09 (Crawled : 12:20) - globenewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: -3.88%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: 1.23%
H: 0.77%
C: -0.05%
ARTL | News | $1.31 0.74% 1.87% 16K
|
Health Technology
|
| O: -8.28%
H: 2.62%
C: -16.76%
update results
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
PFE | News 4 | $26.32 0.23% 0.15% 20M
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
NVO | News | $128.64 2.7% -1.0% 3.5M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: 0.78%
H: 0.94%
C: 0.26%
CCXI | News | $51.99 -0.04%
|
Health Technology
|
| O: -4.88%
H: 1.04%
C: -1.25%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
disease therapy growth
Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report 2022 with Competitive Landscape Analysis of Eli Lily and Co; Novartis; Bristol-Myers Squibb; Roche Diagnostics; Sanofi
Published: 2022-06-17 (Crawled : 12:20) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0
|
Health Technology
|
| O: 0.01%
H: 0.17%
C: 0.17%
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -1.76%
H: 5.75%
C: 5.5%
AZNCF | News | $140.3 1.13% -4.19% 0
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: -0.64%
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: 0.74%
H: 0.52%
C: -3.23%
NVS | News | $97.28 2.27% 1.21% 3.5M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 1.6K
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.41% 7.1M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: 0.59%
H: 0.0%
C: 0.0%
active report roche sanofi market diagnostic
AmoyDx Enters into Master Collaboration Agreement with AstraZeneca for Multiple Companion Diagnostics Programs in China, EU and Japan
Published: 2022-04-18 (Crawled : 12:20) - globenewswire.com
AZN | News | $70.85 1.03% 1.02% 490K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
collaboration diagnostics diagnostic
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
HKIT | $1.33 30.39% 27.14% 39K
|
Technology Services
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
EAST | $1.0835 16.17% 15.21% 100
|
Commercial Services
BOF | $1.17 6.36% 14.73% 15K
|
TSLA | News | $144.68 1.85% 9.01% 93M
|
Consumer Durables
BNED | $0.2064 2.64% 8.96% 1.4M
|
Retail Trade
HLTH | $0.15 6.38% 7.84% 21K
|
LRN 4 | $58.2 0.17% 7.56% 950K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.